PSTV · Categories · Form 4

PSTV - SEC Form 4 insider transactions

PLUS THERAPEUTICS Inc. (PSTV) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PSTV

• 21d
  SEC Form 4 filed by Director Van Es-Johansson An

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 21d
  SEC Form 4 filed by Director Hawkins Richard J

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 21d
  SEC Form 4 filed by Director Guse Kyle

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 21d
  SEC Form 4 filed by Director Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 21d
  SEC Form 4 filed by Director Andrews Ronald Asbury

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 21d
  SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 21d
  SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 47d
  SEC Form 4 filed by Daniels Eric Joseph

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 69d
  SEC Form 4 filed by Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 69d
  SEC Form 4 filed by Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 101d
  SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 101d
  SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 157d
  Chief Executive Officer Hedrick Marc H converted options into 159,681 shares, increasing direct ownership by 89% to 339,787 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 157d
  Chief Financial Officer Sims Andrew John Hugh Macintyre converted options into 38,323 shares, increasing direct ownership by 56% to 106,461 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 248d
  Chief Executive Officer Hedrick Marc H converted options into 159,681 shares, increasing direct ownership by 782% to 180,106 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 248d
  Amendment: SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

  4/A - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 248d
  Chief Financial Officer Sims Andrew John Hugh Macintyre converted options into 38,323 shares, increasing direct ownership by 390% to 48,138 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 248d
  Amendment: SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

  4/A - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 297d
  SEC Form 4 filed by Director Guse Kyle

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 297d
  SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 297d
  SEC Form 4 filed by Director Lenk Robert P

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 297d
  SEC Form 4 filed by Director Hawkins Richard J

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 297d
  SEC Form 4 filed by Director Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 297d
  SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 297d
  SEC Form 4 filed by Director Van Es-Johansson An

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 473d
  SEC Form 4 filed by Director Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 473d
  SEC Form 4 filed by Director Hawkins Richard J

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 473d
  SEC Form 4 filed by Director Petersen Greg

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 473d
  SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 473d
  SEC Form 4 filed by Director Van Es-Johansson An

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 473d
  SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 473d
  SEC Form 4 filed by Director Lenk Robert P

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 634d
  SEC Form 4 filed by Director Hawkins Richard J

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 634d
  SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 634d
  SEC Form 4 filed by Director Van Es-Johansson An

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 634d
  SEC Form 4 filed by Director Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 634d
  SEC Form 4 filed by Director Petersen Greg

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 634d
  SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 634d
  SEC Form 4 filed by Director Lenk Robert P

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 833d
  SEC Form 4 filed by Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 833d
  SEC Form 4 filed by Lafrance Norman D.

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 833d
  SEC Form 4 filed by Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 833d
  SEC Form 4 filed by Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 833d
  SEC Form 4 filed by Lenk Robert P

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 833d
  SEC Form 4 filed by Van Es-Johansson An

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 833d
  SEC Form 4 filed by Hawkins Richard J

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 833d
  SEC Form 4 filed by Petersen Greg

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 906d
  Hedrick Marc H sold $4,053 worth of shares (2,068 units at $1.96), decreasing direct ownership by 92% to 170 units (SEC Form 4)

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 998d
  SEC Form 4: Clowes Howard bought $10,022 worth of shares (6,993 units at $1.43), increasing direct ownership by 149% to 11,693 units

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 1001d
  SEC Form 4: Petersen Greg bought $34,062 worth of shares (20,000 units at $1.70), increasing direct ownership by 480% to 24,166 units

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 1097d
  SEC Form 4 filed by Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 1132d
  SEC Form 4 filed by Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 1207d
  SEC Form 4 filed by Hawkins Richard J

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 1207d
  SEC Form 4 filed by Sims Andrew John Hugh Macintyre

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 1207d
  SEC Form 4 filed by Van Es-Johansson An

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 1207d
  SEC Form 4 filed by Petersen Greg

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 1207d
  SEC Form 4 filed by Lafrance Norman D.

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 1207d
  SEC Form 4 filed by Hedrick Marc H

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 1207d
  SEC Form 4 filed by Clowes Howard

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)
• 1251d
  SEC Form 4: Lenk Robert P sold $472 worth of shares (1,500 units at $0.31), decreasing direct ownership by 15% to 8,500 units

  4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)

Other PSTV categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends